Back
Also listed as
JDHIF
OTC
Day Range
$6.85
$7.00
52-Week Range
$3.81
$9.08
Volume
500
50D / 200D Avg
$8.82
/
$7.85
Prev Close
$6.85
Price History
Financial Trends
Peer Comparison
vs Healthcare sector median (626 peers)
| Metric | Stock | Sector Median |
|---|---|---|
| P/E | 4.2 | 0.4 |
| P/B | 0.4 | 2.9 |
| ROE % | 9.1 | 3.8 |
| Net Margin % | 7.3 | 3.9 |
| Rev Growth 5Y % | 23.5 | 10.0 |
| D/E | 0.0 | 0.2 |
Analyst Price Target
No analyst coverage available
Earnings Estimates
| Period | EPS Est. | Revenue Est. | Analysts |
|---|---|---|---|
| FY2027 |
$0.00
$0.00 – $0.00
|
100 B | 0 |
| FY2026 |
$0.00
$0.00 – $0.00
|
87 B | 0 |
Key Takeaways
Revenue grew 23.53% annually over 5 years — strong growth
Earnings grew 25.64% over the past year
Debt/Equity of 0.01 — conservative balance sheet
Negative free cash flow of 0.0
P/E of 4.19 — trading at a low valuation
ROIC of 4.56% — low return on invested capital
Growth
Revenue Growth (5Y)
23.53%
Revenue (1Y)22.83%
Earnings (1Y)25.64%
FCF Growth (3Y)N/A
Quality
Return on Equity
9.07%
ROIC4.56%
Net Margin7.32%
Op. Margin5.17%
Safety
Debt / Equity
0.01
Current Ratio2.72
Interest Coverage342.21
Valuation
P/E Ratio
4.19
P/B Ratio0.36
EV/EBITDA-2.50
Dividend Yield0.00%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | 22.83% | Revenue Growth (3Y) | 15.52% |
| Earnings Growth (1Y) | 25.64% | Earnings Growth (3Y) | 56.25% |
| Revenue Growth (5Y) | 23.53% | Earnings Growth (5Y) | N/A |
| Profitability | |||
| Revenue (TTM) | 71.44B | Net Income (TTM) | 5.23B |
| ROE | 9.07% | ROA | 6.41% |
| Gross Margin | 24.78% | Operating Margin | 5.17% |
| Net Margin | 7.32% | Free Cash Flow (TTM) | 0.0 |
| ROIC | 4.56% | FCF Growth (3Y) | N/A |
| Safety | |||
| Debt / Equity | 0.01 | Current Ratio | 2.72 |
| Interest Coverage | 342.21 | Dividend Yield | 0.00% |
| Valuation | |||
| P/E Ratio | 4.19 | P/B Ratio | 0.36 |
| P/S Ratio | 0.31 | PEG Ratio | 1.41 |
| EV/EBITDA | -2.50 | Dividend Yield | 0.00% |
| Market Cap | 21.93B | Enterprise Value | -9.25B |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 71.44B | 58.16B | 53.53B | 46.74B | 30.68B |
| Net Income | 5.23B | 4.16B | 2.14B | 380.11M | -1.07B |
| EPS (Diluted) | 1.61 | 1.32 | 0.68 | 0.12 | -0.35 |
| Gross Profit | 17.70B | 13.31B | 11.87B | 9.89B | 7.20B |
| Operating Income | 3.69B | 1.48B | 630.85M | 803.11M | -857.14M |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 81.64B | 71.27B | 64.29B | 61.28B | 48.00B |
| Total Liabilities | 21.53B | 16.03B | 14.92B | 16.49B | 8.15B |
| Shareholders' Equity | 60.11B | 55.23B | 49.36B | 44.78B | 39.85B |
| Total Debt | 636.42M | 258.39M | 214.75M | 199.41M | 201.27M |
| Cash & Equivalents | 31.81B | 22.63B | 15.04B | 18.72B | 17.25B |
| Current Assets | 56.38B | 58.46B | 47.85B | 56.45B | 45.71B |
| Current Liabilities | 20.75B | 15.52B | 14.58B | 16.36B | 8.01B |
Strategy Scores
This stock passed the criteria for 4 strategies
Score = fit strength (0–100)
Rank = position among all matches
Recent Activity
Entered
Deep Value Investing (Seth Klarman)
Mar 24, 2026
Entered
Price/Sales Ratio Focus (Ken Fisher)
Mar 24, 2026
Entered
Defensive Investing (Benjamin Graham)
Mar 24, 2026
Entered
Full Throttle
Mar 24, 2026